HCA

HCA Healthcare is expected to report a year-over-year decline in earnings with higher revenues for Q3 2026. The company's Earnings ESP of -0.73% combined with a Zacks Rank #3 makes it difficult to predict an earnings beat. With recent analyst revisions becoming bearish, HCA does not appear to be a compelling earnings-beat candidate ahead of its October 27 earnings release.

The HCA Healthcare Foundation awarded a $25,000 grant to Waypoint (formerly Virginia Home for Boys and Girls) to expand its Therapeutic Resources team and support free Youth Mental Health First Aid and Community Resiliency Model trainings across Virginia. The funding, part of HCA Healthcare Foundation's $75 million Healthier Tomorrow Fund, will help train more adults to recognize and respond to youth mental health challenges.

Pomerantz LLP is investigating potential securities fraud claims on behalf of HCA Healthcare investors following the company's July 14, 2026 announcement of sharply lowered full-year profit guidance due to an unfavorable shift in payer mix that impacted revenue by approximately $400 million in Q2. The news triggered a 6.95% stock price decline.

Establishment Labs (ESTA) is expected to report a quarterly loss of $0.27 per share with revenues of $66.64 million, up 23.9% year-over-year. The company has a positive Earnings ESP of +20.76% combined with a Zacks Rank #3, suggesting it will likely beat consensus EPS estimates. However, the company has a mixed earnings surprise history, beating estimates only twice in the last four quarters.

Danaher reported Q3 2026 earnings of $2.11 per share, beating consensus estimates of $1.92 and delivering a 9.90% earnings surprise. Revenue of $6.55 billion slightly exceeded expectations.

Despite the strong earnings beat, DHR shares have underperformed the S&P 500 by 14.4% year-to-date. The stock holds a Zacks Rank #2 (Buy) rating, though the Medical Services industry ranks in the bottom 34% of sectors.

Joint Commission announced the appointment of Ken Grubbs, DNP, MBA, RN, as chief operating officer, marking the first time a nurse has held this position in the organization's 75-year history. Dr. Grubbs, who brings over two decades of healthcare leadership experience across clinical operations, patient safety, and quality improvement, will assume the role on January 1, 2027, succeeding James Merlino, MD, who becomes president and CEO.

Zacks highlights strong stock performance from its research methodologies, with HF Sinclair surging 49% after a Rank upgrade and FirstCash gaining 36.3% since the 2026 Top 10 list launch. The article reviews market conditions showing a shift toward value stocks amid inflation concerns and elevated Treasury yields, while showcasing performance of various Zacks portfolios including the Focus List, ECAP, and ECDP.

Tenet Healthcare (THC) is accelerating share buybacks and raising 2026 free cash flow guidance to $1.825-$2.055 billion, supported by 27.1% year-over-year growth in operating cash flow to $2.2 billion. The company has $2.1 billion remaining in buyback authorization while continuing to invest in growth initiatives and managing debt obligations.